- Evaluation of a drug label including patient reported outcomes (Limit 2 pages)The evaluation of the PRO will include the following information:a) Company, generic, brand name and therapeutic class of the product
Brand name: HUMIRA
Generic name: adalimumab Therapeutic class of the product: Antirheumatic b) AHFS or other Drug Classification
AHFS: 92.00
c) FDA Approved Indication
Humira got FDA approval in the year 2002
e) Identity the type of studies that were conducted by the pharmaceutical company to support the PRO claims. e.1. Trial design, randomization and blinding procedures Ans: Mostly randomised clinical trials were designed to learn about the effects of Humira. Blinding was not performed to all ...
